Symbols / AKBA Stock $1.42 +0.71% Akebia Therapeutics, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • United States • NCM
AKBA (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. Its product portfolio includes Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent (DD) and non-dialysis dependent (NDD) patients; and Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD and the treatment of iron deficiency anemia in adult patients with NDD-CKD. The company is also developing AKB-9090, which is in Phase 2 clinical trial for treating cardiac surgery-related acute kidney injury and acute respiratory distress syndrome; and AKB-10108 for the treatment of retinopathy of prematurity in neonates. The company has license and collaboration agreements with Tanabe Pharma Corporation for the development and commercialization of Vafseo in Japan and other Asian countries; Vafseo License and Collaboration Agreements; CSL Vifor Agreements; Averoa License Agreement; License Agreement with Panion & BF Biotech, Inc.; Cyclerion Therapeutics License Agreement; and Q32 Asset Purchase Agreement. Akebia Therapeutics, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Stock Fundamentals
Scroll to Statements
Market Cap 380.39M Enterprise Value 394.33M Income -5.34M Sales 236.20M Book/sh 0.12 Cash/sh 0.69
Dividend Yield — Payout 0.00% Employees 194 IPO — P/E — Forward P/E -14.95
PEG — P/S 1.61 P/B 11.54 P/C — EV/EBITDA 14.46 EV/Sales 1.67
Quick Ratio 1.42 Current Ratio 1.55 Debt/Eq 609.57 LT Debt/Eq — EPS (ttm) -0.02 EPS next Y -0.10
EPS Growth — Revenue Growth 23.90% Earnings 2026-05-07 ROA 5.44% ROE — ROIC —
Gross Margin 82.92% Oper. Margin -10.50% Profit Margin -2.26% Shs Outstand 267.88M Shs Float 262.21M Short Float 9.91%
Short Ratio 9.32 Short Interest — 52W High 4.08 52W Low 1.14 Beta 0.37 Avg Volume 3.03M
Volume 1.49M Target Price $4.40 Recom Strong_buy Prev Close $1.41 Price $1.42 Change 0.71%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$4.40
Mean price target
2. Current target
$1.42
Latest analyst target
3. DCF / Fair value
$4.61
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.42
Low
$3.00
High
$6.00
Mean
$4.40

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-07 reit BTIG Buy → Buy $4
2026-02-25 main BTIG Buy → Buy $4
2026-02-06 main Piper Sandler Overweight → Overweight $4
2026-02-06 reit HC Wainwright & Co. Buy → Buy $6
2025-12-02 reit BTIG Buy → Buy $5
2025-12-02 reit HC Wainwright & Co. Buy → Buy $6
2025-10-30 main HC Wainwright & Co. Buy → Buy $6
2025-10-29 main BTIG Buy → Buy $5
2025-04-28 init Leerink Partners — → Outperform $7
2025-04-04 reit HC Wainwright & Co. Buy → Buy $8
2025-04-01 init Jefferies — → Buy $6
2025-03-14 main Piper Sandler Overweight → Overweight $6
2025-03-14 reit HC Wainwright & Co. Buy → Buy $8
2025-01-23 reit HC Wainwright & Co. Buy → Buy $8
2025-01-14 reit HC Wainwright & Co. Buy → Buy $8
2024-10-23 reit HC Wainwright & Co. Buy → Buy $8
2024-10-10 reit HC Wainwright & Co. Buy → Buy $8
2024-10-08 reit HC Wainwright & Co. Buy → Buy $8
2024-09-06 reit HC Wainwright & Co. Buy → Buy $8
2024-08-12 main HC Wainwright & Co. Buy → Buy $8
News
RSS: Latest AKBA news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-04 BUTLER JOHN P Chief Executive Officer — 69,270 $1.25 $86,588
2026-02-02 BUTLER JOHN P Chief Executive Officer — 175,250 $1.41 $247,102
2026-02-02 BUTLER JOHN P Chief Executive Officer — 341,305 $1.39 $474,414
2026-02-02 GRUND NICHOLAS Officer — 84,829 $1.39 $117,912
2026-02-02 OSTROWSKI ERIK Chairman of the Board — 34,951 $1.39 $48,582
2026-02-02 MALABRE RICHARD C. Officer — 49,524 $1.39 $68,838
2026-02-02 RUCCI CAROLYN M Officer — 69,772 $1.39 $96,983
2026-02-02 BURKE STEVEN KEITH Officer — 67,658 $1.39 $94,045
2026-01-30 BUTLER JOHN P Chief Executive Officer — 743,000 $0.00 $0
2026-01-30 GRUND NICHOLAS Officer — 204,000 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
236.20
+47.46%
160.18
-17.70%
194.62
-33.46%
292.48
Operating Revenue
236.20
+47.46%
160.18
-17.70%
194.62
-33.46%
292.48
Cost Of Revenue
39.46
-37.54%
63.18
-14.80%
74.15
-13.34%
85.57
Reconciled Cost Of Revenue
39.46
-37.54%
63.18
-14.80%
74.15
-13.34%
85.57
Gross Profit
196.73
+102.81%
97.00
-19.48%
120.47
-41.78%
206.92
Operating Expense
173.24
+17.51%
147.42
-11.49%
166.55
-38.72%
271.76
Research And Development
62.36
+65.62%
37.65
-40.31%
63.08
-51.47%
129.99
Selling General And Administration
107.48
+0.88%
106.55
+6.30%
100.23
-27.68%
138.60
Selling And Marketing Expense
—
—
100.23
-27.68%
138.60
General And Administrative Expense
—
—
—
141.87
Other Gand A
—
—
—
141.87
Other Operating Expenses
3.40
+5.47%
3.22
-0.53%
3.24
+1.95%
3.17
Total Expenses
212.70
+1.00%
210.59
-12.51%
240.70
-32.64%
357.33
Operating Income
23.50
+146.61%
-50.41
-9.42%
-46.08
+28.95%
-64.85
Total Operating Income As Reported
23.50
+146.56%
-50.47
-9.11%
-46.26
+42.74%
-80.78
EBITDA
21.73
+258.35%
-13.72
-65.99%
-8.27
+79.76%
-40.84
Normalized EBITDA
24.83
+293.71%
-12.82
-69.50%
-7.56
+68.50%
-24.00
Reconciled Depreciation
1.27
-96.62%
37.50
-0.33%
37.63
-0.19%
37.70
EBIT
20.46
+139.94%
-51.23
-11.62%
-45.89
+41.57%
-78.54
Total Unusual Items
-3.10
-242.43%
-0.91
-28.37%
-0.70
+95.81%
-16.84
Total Unusual Items Excluding Goodwill
-3.10
-242.43%
-0.91
-28.37%
-0.70
+95.81%
-16.84
Special Income Charges
0.00
+100.00%
-0.57
+18.44%
-0.70
+95.81%
-16.84
Other Special Charges
—
0.52
-1.34%
0.52
-42.16%
0.91
Restructuring And Mergern Acquisition
0.00
-100.00%
0.06
-67.96%
0.18
-98.86%
15.93
Net Income
-5.34
+92.30%
-69.41
-33.67%
-51.92
+44.89%
-94.23
Pretax Income
-3.72
+94.64%
-69.41
-33.67%
-51.92
+44.89%
-94.23
Net Non Operating Interest Income Expense
-24.18
-32.96%
-18.18
-201.48%
-6.03
+61.55%
-15.69
Interest Expense Non Operating
24.18
+32.96%
18.18
+201.48%
6.03
-61.55%
15.69
Net Interest Income
-24.18
-32.96%
-18.18
-201.48%
-6.03
+61.55%
-15.69
Interest Expense
24.18
+32.96%
18.18
+201.48%
6.03
-61.55%
15.69
Other Income Expense
-3.04
-274.97%
-0.81
-545.60%
0.18
+101.33%
-13.69
Other Non Operating Income Expenses
0.06
-38.30%
0.09
-89.40%
0.89
-71.81%
3.15
Gain On Sale Of Security
-3.10
-839.09%
-0.33
—
—
Tax Provision
1.62
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
-0.65
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-5.34
+92.30%
-69.41
-33.67%
-51.92
+44.89%
-94.23
Net Income From Continuing Operation Net Minority Interest
-5.34
+92.30%
-69.41
-33.67%
-51.92
+44.89%
-94.23
Net Income From Continuing And Discontinued Operation
-5.34
+92.30%
-69.41
-33.67%
-51.92
+44.89%
-94.23
Net Income Continuous Operations
-5.34
+92.30%
-69.41
-33.67%
-51.92
+44.89%
-94.23
Normalized Income
-2.90
+95.77%
-68.50
-33.75%
-51.22
+33.81%
-77.39
Net Income Common Stockholders
-5.34
+92.30%
-69.41
-33.67%
-51.92
+44.89%
-94.23
Diluted EPS
-0.02
+93.94%
-0.33
-17.86%
-0.28
+45.10%
-0.51
Basic EPS
-0.02
+93.94%
-0.33
-17.86%
-0.28
+45.10%
-0.51
Basic Average Shares
257.16
+21.91%
210.95
+12.53%
187.47
+2.56%
182.78
Diluted Average Shares
257.16
+21.91%
210.95
+12.53%
187.47
+2.56%
182.78
Diluted NI Availto Com Stockholders
-5.34
+92.30%
-69.41
-33.67%
-51.92
+44.89%
-94.23
Total Other Finance Cost
—
—
—
15.69
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
376.56
+70.65%
220.67
-8.70%
241.70
-32.12%
356.05
Current Assets
252.96
+122.22%
113.83
-3.65%
118.15
-36.20%
185.18
Cash Cash Equivalents And Short Term Investments
184.84
+256.36%
51.87
+20.84%
42.92
-52.55%
90.47
Cash And Cash Equivalents
184.84
+256.36%
51.87
+20.84%
42.92
-52.55%
90.47
Other Short Term Investments
—
—
—
—
Receivables
47.03
+36.85%
34.37
-12.53%
39.29
-2.47%
40.28
Accounts Receivable
47.03
+36.85%
34.37
-12.53%
39.29
-2.47%
40.28
Gross Accounts Receivable
49.72
+39.75%
35.58
-11.75%
40.32
—
Allowance For Doubtful Accounts Receivable
-2.69
-122.03%
-1.21
-17.78%
-1.03
—
Inventory
15.61
-3.90%
16.24
+3.52%
15.69
-27.25%
21.57
Work In Process
12.65
+5.15%
12.03
+179.99%
4.30
-45.55%
7.89
Finished Goods
2.96
-29.75%
4.21
-63.03%
11.39
-16.69%
13.68
Prepaid Assets
0.00
-100.00%
4.03
-72.19%
14.49
—
Restricted Cash
1.70
0.00
—
—
Other Current Assets
3.77
-48.49%
7.32
+27.23%
5.75
-82.49%
32.86
Total Non Current Assets
123.61
+15.70%
106.84
-13.53%
123.55
-27.69%
170.87
Net PPE
4.88
-53.11%
10.42
-35.07%
16.05
-53.32%
34.37
Gross PPE
4.88
-53.11%
10.42
-35.07%
16.05
-53.32%
34.37
Accumulated Depreciation
—
—
—
-9.32
Properties
—
—
—
0.00
Machinery Furniture Equipment
—
—
—
3.10
Other Properties
4.88
-53.11%
10.42
-35.07%
16.05
-53.32%
34.37
Leases
—
—
—
8.69
Goodwill And Other Intangible Assets
59.04
+0.00%
59.04
-37.90%
95.09
-27.49%
131.13
Goodwill
59.04
+0.00%
59.04
+0.00%
59.04
+0.00%
59.04
Other Intangible Assets
—
—
36.04
-50.00%
72.08
Other Non Current Assets
59.68
+59.67%
37.38
+200.87%
12.42
+131.25%
5.37
Total Liabilities Net Minority Interest
343.95
+27.46%
269.86
-0.89%
272.29
-22.39%
350.82
Current Liabilities
162.94
+101.37%
80.91
-18.98%
99.87
-22.90%
129.54
Payables And Accrued Expenses
48.88
+24.75%
39.18
+6.77%
36.70
+0.48%
36.53
Payables
26.18
+72.50%
15.18
+3.72%
14.63
-18.79%
18.02
Accounts Payable
21.18
+39.56%
15.18
+3.72%
14.63
-18.79%
18.02
Other Payable
5.00
—
—
—
Current Accrued Expenses
22.70
-5.44%
24.00
+8.78%
22.07
+19.24%
18.51
Pensionand Other Post Retirement Benefit Plans Current
11.02
+19.84%
9.19
+11.90%
8.22
-30.92%
11.89
Current Debt And Capital Lease Obligation
3.55
-34.30%
5.40
-75.44%
21.99
-40.15%
36.74
Current Debt
—
—
17.50
-45.31%
32.00
Other Current Borrowings
—
—
17.50
-45.31%
32.00
Current Capital Lease Obligation
3.55
-34.30%
5.40
+20.24%
4.49
-5.33%
4.74
Current Deferred Liabilities
2.68
0.00
0.00
-100.00%
3.74
Current Deferred Revenue
2.68
0.00
0.00
-100.00%
3.74
Other Current Liabilities
86.52
+1315.08%
6.11
+32.86%
4.60
-30.02%
6.58
Total Non Current Liabilities Net Minority Interest
181.02
-4.19%
188.94
+9.58%
172.42
-22.08%
221.29
Long Term Debt And Capital Lease Obligation
48.25
+14.23%
42.24
+61.65%
26.13
-58.55%
63.04
Long Term Debt
48.25
+24.70%
38.69
+125.18%
17.18
-49.58%
34.08
Long Term Capital Lease Obligation
0.00
-100.00%
3.55
-60.36%
8.95
-69.11%
28.96
Long Term Provisions
22.61
-40.53%
38.01
-5.19%
40.09
-2.19%
40.99
Non Current Deferred Liabilities
—
0.00
-100.00%
43.30
+0.00%
43.30
Non Current Deferred Revenue
—
0.00
-100.00%
43.30
+0.00%
43.30
Other Non Current Liabilities
107.18
+3.54%
103.51
+64.57%
62.90
-14.07%
73.20
Stockholders Equity
32.61
+166.30%
-49.19
-60.82%
-30.58
-684.78%
5.23
Common Stock Equity
32.61
+166.30%
-49.19
-60.82%
-30.58
-684.78%
5.23
Capital Stock
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Common Stock
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
265.42
+18.05%
224.85
+15.55%
194.58
+5.67%
184.14
Ordinary Shares Number
265.42
+18.05%
224.85
+15.55%
194.58
+5.67%
184.14
Additional Paid In Capital
1,716.31
+5.35%
1,629.17
+3.22%
1,578.36
+1.03%
1,562.25
Retained Earnings
-1,683.70
-0.32%
-1,678.36
-4.31%
-1,608.95
-3.33%
-1,557.03
Gains Losses Not Affecting Retained Earnings
0.01
+0.00%
0.01
+0.00%
0.01
+0.00%
0.01
Other Equity Adjustments
0.01
+0.00%
0.01
+0.00%
0.01
+0.00%
0.01
Total Equity Gross Minority Interest
32.61
+166.30%
-49.19
-60.82%
-30.58
-684.78%
5.23
Total Capitalization
80.86
+870.68%
-10.49
+21.71%
-13.40
-134.09%
39.31
Working Capital
90.02
+173.47%
32.92
+80.08%
18.28
-67.15%
55.65
Invested Capital
80.86
+870.68%
-10.49
-355.96%
4.10
-94.25%
71.31
Total Debt
51.80
+8.73%
47.64
-1.00%
48.12
-51.77%
99.78
Capital Lease Obligations
3.55
-60.34%
8.95
-33.42%
13.44
-60.13%
33.70
Net Tangible Assets
-26.43
+75.58%
-108.23
+13.88%
-125.67
+0.18%
-125.90
Tangible Book Value
-26.43
+75.58%
-108.23
+13.88%
-125.67
+0.18%
-125.90
Current Provisions
10.29
-51.05%
21.02
-25.87%
28.36
-16.73%
34.06
Derivative Product Liabilities
2.98
-42.43%
5.18
0.00
-100.00%
0.76
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
67.99
+267.22%
-40.66
-73.88%
-23.38
+68.03%
-73.15
Cash Flow From Continuing Operating Activities
67.99
+267.22%
-40.66
-73.88%
-23.38
+68.03%
-73.15
Net Income From Continuing Operations
-5.34
+92.30%
-69.41
-33.67%
-51.92
+44.89%
-94.23
Depreciation Amortization Depletion
1.27
-96.62%
37.50
-0.33%
37.63
-0.19%
37.70
Depreciation
1.27
-13.20%
1.46
-7.76%
1.58
-4.17%
1.65
Amortization Cash Flow
0.00
-100.00%
36.04
+0.00%
36.04
0.00%
36.04
Depreciation And Amortization
1.27
-96.62%
37.50
-0.33%
37.63
-0.19%
37.70
Amortization Of Intangibles
0.00
-100.00%
36.04
+0.00%
36.04
0.00%
36.04
Other Non Cash Items
37.40
+114.46%
17.44
+1059.57%
1.50
+102.40%
-62.62
Stock Based Compensation
11.28
+45.12%
7.78
-16.55%
9.32
-47.80%
17.85
Provisionand Write Offof Assets
—
4.21
+166.33%
1.58
-94.78%
30.24
Asset Impairment Charge
3.98
-21.64%
5.08
+221.77%
1.58
-94.78%
30.24
Deferred Tax
—
—
—
—
Deferred Income Tax
—
—
—
—
Operating Gains Losses
2.93
+369.07%
0.62
+182.11%
-0.76
-16.21%
-0.65
Gain Loss On Investment Securities
3.10
+839.09%
0.33
+143.42%
-0.76
+28.30%
-1.06
Gain Loss On Sale Of PPE
-0.17
0.00
0.00
—
Change In Working Capital
16.47
+141.52%
-39.68
-91.42%
-20.73
-1336.38%
-1.44
Change In Receivables
-14.14
-449.53%
4.05
+307.04%
0.99
-91.20%
11.30
Changes In Account Receivables
-14.14
-449.53%
4.05
+307.04%
0.99
-91.20%
11.30
Change In Inventory
-23.12
+18.58%
-28.40
-1017.27%
-2.54
-113.32%
19.09
Change In Prepaid Assets
7.58
-14.78%
8.89
-24.88%
11.84
+1019.00%
1.06
Change In Payables And Accrued Expense
51.61
+464.98%
-14.14
+7.36%
-15.27
+58.18%
-36.50
Change In Accrued Expense
48.53
+479.82%
-12.78
-27.50%
-10.02
+73.63%
-38.01
Change In Payable
3.08
+325.95%
-1.36
+73.99%
-5.24
-449.37%
1.50
Change In Account Payable
3.08
+325.95%
-1.36
+73.99%
-5.24
-449.37%
1.50
Change In Other Working Capital
2.68
—
-3.74
-180.32%
4.65
Change In Other Current Assets
-2.62
-521.54%
0.62
+145.70%
-1.36
+75.80%
-5.62
Change In Other Current Liabilities
-5.51
+48.47%
-10.70
-0.38%
-10.65
-332.21%
4.59
Investing Cash Flow
-7.93
-23918.18%
-0.03
0.00
+100.00%
-0.11
Cash Flow From Continuing Investing Activities
-7.93
-23918.18%
-0.03
0.00
+100.00%
-0.11
Net PPE Purchase And Sale
-0.12
-260.61%
-0.03
0.00
+100.00%
-0.11
Purchase Of PPE
-0.29
-781.82%
-0.03
0.00
+100.00%
-0.11
Sale Of PPE
0.17
0.00
0.00
—
Capital Expenditure
-8.10
-24439.39%
-0.03
—
-0.11
Net Investment Purchase And Sale
—
—
—
0.00
Purchase Of Investment
—
—
—
0.00
Sale Of Investment
—
—
—
0.00
Net Intangibles Purchase And Sale
-7.81
0.00
0.00
—
Purchase Of Intangibles
-7.81
0.00
0.00
—
Financing Cash Flow
72.93
+46.84%
49.66
+297.03%
-25.21
-272.67%
14.60
Cash Flow From Continuing Financing Activities
72.93
+46.84%
49.66
+297.03%
-25.21
-272.67%
14.60
Net Issuance Payments Of Debt
9.54
+20.72%
7.90
+124.69%
-32.00
+3.03%
-33.00
Issuance Of Debt
10.00
-77.78%
45.00
0.00
0.00
Repayment Of Debt
-0.46
+98.75%
-37.10
-15.93%
-32.00
+3.03%
-33.00
Long Term Debt Issuance
10.00
-77.78%
45.00
0.00
0.00
Long Term Debt Payments
-0.46
+98.75%
-37.10
-15.93%
-32.00
+3.03%
-33.00
Net Long Term Debt Issuance
9.54
+20.72%
7.90
+124.69%
-32.00
+3.03%
-33.00
Net Common Stock Issuance
66.68
+56.34%
42.65
+527.84%
6.79
-9.80%
7.53
Common Stock Payments
—
-1.27
0.00
—
Repurchase Of Capital Stock
—
-1.27
0.00
—
Proceeds From Stock Option Exercised
1.68
+337.40%
0.39
+38400.00%
0.00
-98.51%
0.07
Net Other Financing Charges
-4.97
-291.04%
-1.27
—
40.00
Changes In Cash
132.99
+1382.48%
8.97
+118.46%
-48.59
+17.18%
-58.67
Beginning Cash Position
53.55
+20.12%
44.58
-52.15%
93.17
-38.64%
151.84
End Cash Position
186.54
+248.35%
53.55
+20.12%
44.58
-52.15%
93.17
Free Cash Flow
59.89
+247.19%
-40.69
-74.02%
-23.38
+68.08%
-73.27
Interest Paid Supplemental Data
6.08
+20.75%
5.04
-16.90%
6.06
-10.30%
6.75
Amortization Of Securities
—
—
—
0.00
Common Stock Issuance
66.68
+56.34%
42.65
+527.84%
6.79
-9.80%
7.53
Issuance Of Capital Stock
66.68
+56.34%
42.65
+527.84%
6.79
-9.80%
7.53
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category